Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy.
| Image |  |
|---|---|
| Description | scientific article published on 16 November 2011 |
| Author/s |
author: Eva M Ciruelos |
| Publication date | November 16, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |